Background and aim: The kidney is involved in the regulation of thyroid hormones metabolism. Numerous abnormalities of thyroid hormones in end-stage kidney disease (ESKD) have been described. The aim of our study was to estimate the prevalence of thyroid dysfunction and its relation to Echocardiologic abnormalities in patients with end stage kidney disease.
surprising, therefore, that impairment in kidney function leads to disturbed thyroid physiology [1] . Chronic renal failure affects thyroid function in multiple way, including low circulating thyroid hormone concentration, altered peripheral hormone metabolism, disturbed binding to carrier proteins, possible reduction in tissue thyroid hormone content, and increase iodine store in thyroid glands. Both plasma triiodothyronine (T3) and thyroxin (T4) are reduced [2] .
Thyroid function has been extensively evaluated in patients with chronic kidney disease, however the results are variable, primary hyperthyroidism is extremely rare, while the prevalence of hypothyroidism is increased in patients with chronic renal failure [3] . The prevalence of hypothyroidism was increased in persons with reduced glomerular filtration rate (GFR), ranging from 5.4% for persons with estimated GFR ≥ 90 mL/min/1.73 m 2 to more than 20% in persons with estimated GFR < 60 mL/min/1.73 m 2 [4] . In spite of a large number of previous investigations of thyroid function abnormalities in end stage kidney disease (ESKD) patients, the echocardiographic findings were not included in the analysis in most of these studies. Therefore, the aim of this study was to evaluate thyroid function abnormalities and its relation to echocardiographic abnormalities in ESKD patients.
Introduction
The kidney plays an important role in the metabolism, degradation and excretion of several thyroid hormones. It is not peritoneal dialysis or kidney transplantation prior to hemodialysis; patients who have been receiving thyroid hormone replacement or suppressive therapy due to overt thyroid disease; patients who have been receiving medications affecting thyroid hormone levels, such as amiodarone, glucocorticoids, and lithium; patients who have active malignancy.
Each patient underwent complete history and physical examination with special emphasis on age, gender, body mass index, primary renal disease, comorbidities, and medications. Measurement of thyroid hormones was performed. As heparin may interfere with competitive assays, blood was drawn just before the start of hemodialysis procedure from the inserted dialysis needle or from the arterial port of dialysis circuit, before contact of blood with dialyzer and before heparin administration. This ensured that there was an interval of at least 48 hours since the last heparin application. The battery of tests thus included: TSH determined by immune radiometric assay, reference range (RR) 0.17-4.05 µIU/ mL; total T4, RIA RR 5.4-12.4 µg/dL; total T3, RIA, RR 78-182 ng/ dL; freeT4 measured by RIA, RR 0.89-1.79 ng/dL; free T3, RIA, RR 1.6-3.77 pg/dL (IMMUNOTECH s.r.o. -Radiovo1-102 27, PragueCzech Republic). Transthoracic Echocardiography was performed on a non-dialysis day, close to the time of discharge based on the imaging protocol recommended by American Society of Echocardiography [5] . All patients were informed about the content of the study and gave their written approvals before enrollment. All procedures were performed in accordance with the ethical standards of Al-Azhar University's committee on human experiments.
Statistical Analysis
Statistical analysis was performed using SPSS for Windows, version 20.0 (SPSS, Inc.). Values were expressed as mean ± Standard deviation (SD) and as percentage for categorical parameters. Independent t-test was applied for comparison between two independent groups with parametrical data. Chi-square test was applied for estimating the occurrence of categorical variables. Pearson's correlation coefficient was used to test the correlation between thyroid function tests and echocardiographic parameters. P-values < 0.05 were considered statistically significant.
Results
Characteristics of the 80 participants are summarized in the table 1, table 2 and table 3 . The major etiology of ESKD is hypertension (31.7%) and the major comorbid disease is diabetes mellitus (30%). T3 and T4 levels are significantly low (68.6 ± 21.4 ng/dL, 5.1 ± 2.1 µg/dL) as compared to control (104.1 ± 20.2 ng/dL, 7.8 ± 2.0 µg/dL). No significant differences are detected as regards TSH, FT3, and FT4 levels. The left ventricular mass index (LVMI), septal wall thickness (SWT), posterior wall thickness (PWT) and left atrium diameter (LAD) are significantly high as compared to control. On the other hand, the left ventricular ejection fraction (LVEF) is significantly low ( Table 3 ). The patients with echocardiographic abnormalities have a significantly low T3 as compared to patients with normal echocardiographic studies ( Table 4) . T3 levels show negative correlations with LVMI, LVEDD, SWT and PWT and a positive correlation with LVEF. Moreover, T4 levels have a positive correlation with LVEF. No significant correlations between FT3, FT4, TSH and Echocardiographic data can be observed detected (Table 5) .
Discussion
Most studies of thyroid hormones in clinically euthyroid patients with varying degrees of chronic renal failure showed significant decrease in total T3, total T4 and free T3 (FT3) levels compared with control [6, 7] . A low T3 and T4 syndrome is evident when glomerular filtration rate (GFR) is reduced below 30 ± 16 ml/min [7] . Usually there is more distinct suppression of T3 than of T4 [8] . The concentrations of reverse T3 (rT3), the inactive metabolite of T4 in plasma are usually low but normal or even elevated values have been reported by some authors [8, 9] . Similar to findings of this study, the previous studies have demonstrated that the most common thyroid imbalance in patients on hemodialysis was low T3 syndrome, while FT3 levels generally remain within the normal limits [6, 10] . Ozen, et al. [11] demonstrated that up to 70% of stage 5 CKD patients have low T3. Soffer, et al. found that low serum levels of thyroxine in 69.5% of the patients studied and of triiodothyronine (T3) in 46.5% and 13.0% had high levels of TSH [12] .
The reduction in thyroid hormone may be due to the effect of chronic renal failure on the thyroid hormones which include altered peripheral metabolism like impairment of peripheral deiodination of T4 which is the mainsource of T3. Due to reduced deiodinase activity, tissue and circulating levels of the active form of the thyroid hormone and T3are low in kidney failure [13] . Toxic uremic solute such as urea, creatinine, indoles and phenols inhibits protein binding of T4 [8] . Furthermore, systemic inflammation [14, 15] and metabolic acidosis [14] may alter thyroid function in CKD patients. The concentration of serum iodine in patients with CKD is higher due to lower iodine clearance caused by reduced glomerular filtration. Elevated levels of serum inorganic iodine in patients with CKD may potentially block thyroid hormone synthesis (Wolff-Chaikoff effect) [16] . In contrast, the thyroid-pituitary feedback loop seems to remain intact, because steady-stateplasma TSH remains substantially normal [3] . The Reduced renal clearance may contribute to delayed recovery, since TSH and TRH are normally cleared by the kidney [17] . Low T3 associated with endothelial dysfunction, a harbinger of atherosclerosis, in stage 3 and 4 CKD patients [10] , as well as cardiomyopathy [18] and with high risk of death in stage 5 CKD patients [19] . The cardiovascular mortality in these individuals is 10-to 20-fold more frequent than in the general population [20] . Although more than 50% of the individuals starting a dialysis program present some type of pre-existent cardiovascular disease, the traditional risk factors for cardiovascular disease do not completely explain this excess risk, which seems to be influenced by the so-called non-traditional risk factors associated with CKD. This set of factors accelerates the course of coronary artery disease (CAD) and is associated with a higher prevalence of ventricular hypertrophy, myocardial fibrosis, valvulopathies, arrhythmias and sudden death [21] .
The cardiomiopathy of the patient undergoing dialysis is mainly due to the presence of ischemic cardiopathy and morphofunctional alterations of the left ventricle (LV) in response to pressure and volume overload. The physiopathology of the transformations induced by uremia in the left ventricular chamber is complex and multifactorial [22] . Arteriovenous fistula, which was used for vascular access in patients with ESRD, increases stroke volume load on the left ventricle and this may contributes to LVH and may results in LV systolic and diastolic dysfunction with time [23] . The left ventricular dysfunction and hypertrophy were most common echocardiographic findings and statistically correlated with anemia and presence of hypertension [24, 25] .
In current study, significant numbers of patients have echocardiologic abnormalities (71.7% of patients), majority of these patients have left ventricular hypertrophy (70%), 55% have left atrial dilatation and 41.7% have systolic dysfunction. Similar findings have been demonstrated by Foley, et al. [26] they reported that abnormalities of left ventricular structure and functions were very frequent on baseline echocardiography: 73.9% had left ventricular hypertrophy, 35.5% had left ventricular dilatation and 14.8% had systolic dysfunction in ESRD patients. Singh, et al. [27] reported that LVH in 76.92%, diastolic dysfunction in 72% but did not find systolic dysfunction in CKD patients. Zoccali, et al. [28] found 77% of patients had LVH and 22% had systolic dysfunction by in haemodialysis patients. Agarwal, et al. [29] had observed diastolic dysfunction in 60% and systolic dysfunction in 15% of patients. In addition, Laddha, et al. found that in hypertensive patients with ESRD LVH was present in 87.5%, diastolic dysfunction was present in 72.9% as measured by abnormal E/A ratio, systolic dysfunction as measured by reduced LVEF was present in 29.2% and pericardial effusion observed in 14.6%. In normotensive patient with ESRD LVH was present in 45.5%, diastolic dysfunction was present in 40.9%, and systolic dysfunction was present in 13.6% and pericardial effusion observed in 13.6% patients [25] .
Left ventricular dysfunction and LVH are considered a maladaptive response to hypertension, volume overload, anaemia, hyperphosphataemia, inflammation and other risk factors [30] . It is important to recognize that part of the alteration in the geometry of LV in CKD patients can be related to the moment at which the echocardiogram was performed. Shortly after the dialysis session, it is common to see a reduction in diastolic diameter of the LV and an increase in the thickness of the LV wall as a pure consequence of volume depletion by ultrafiltration. While, examination shortly before beginning the session can shows LV dilatation that will be 'converted' into concentric at the end of the session. Such fluctuation could be minimized by performing the echocardiogram during the interdialytic period [31] .
Thyroid diseases can result in a wide range of cardiovascular manifestations and complications like atrial fibrillation, cardiomyopathy, and congestive heart failure. It is well known that T3 increases cardiac output by affecting tissue oxygen consumption, vascular resistance, blood volume, cardiac contractility, and heart rate [32] . Therefore, low T3, even in the normal range, has been suggested to be associated with various cardiovascular diseases in ESRD patients, which has been clarified by several previous studies [9, 16, 33, 34] . Independently from the presence of primary thyroid hypofunction and differently from other organs, the heart is particularly vulnerable to reductions in biologically active T3 in plasma because cardiomyocytes have a negligible capability to generate T3 from locally converted precursor T4. Consequently, when circulating T3 is low, the myocardium may become relatively hypothyroid [35] .
The large numbers of previous investigations were on the prognostic value of low T3 for all-cause and cardiovascular (CV) mortality in ESRD patients and echocardiographic findings were not included in the analysis in most of these studies. In this study, we have found majority of patients who have echocardiographic abnormalities (90.7%) have thyroid function abnormalities. The thyroid abnormalities are frequent among patients with left ventricular hypertrophy (90.5%). Moreover, in concordance with our observations previous studies [8, [35] [36] [37] [38] have been demonstrated that LV systolic function was depressed and LVMI was increased in the presence of low T3. Correction of malnutrition, anemia, acidosis, and thyroid hormone has associated with improvement of LVMI, LVEF [39, 40] . Therapeutic use of thyroid hormone has not been adequately studied [41] . Finally, the small number of patients was the first limitation in this study. Diastolic dysfunctions are a frequent finding among ESKD patients who have thyroid abnormalities and must be included for better assessment.
Conclusions
The majority ofhemodialysis patients have echocardiographic abnormalities. The left ventricular hypertrophy and left atrial dilatation were the most common abnormalities. Echocardiographic abnormalities were linked by thyroid abnormalities especially low T3. Screening for early detection of thyroid disorders is useful and important. This is just a preliminary report regarding thyroid dysfunction and its cardiovascular complications and future studies with a larger sample size may be considered.
